PAR-24-124 - NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 2

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Interventions to Reduce Chronic Inflammation and Inflammation-Related Morbidity in People Living with HIV/AIDS NOT-AT-24-035 NCCIH NIA Mar 4, 2024 Nov 14, 2024 R01, R61/R33, R34, R21
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research NOT-AI-22-004 NIAID NIAMS NCCIH NCI Nov 23, 2021 Jan 8, 2025 R03, R21, U01, U44, R01, R34, P01, R61/R33
For technical issues E-mail OER Webmaster